![Oral small molecule GLP-1 receptor agonist danuglipron (PF-06882961) results in glucose lowering and body weight loss over 16 weeks in adults with type 2 diabetes - Media Centre | EASD Oral small molecule GLP-1 receptor agonist danuglipron (PF-06882961) results in glucose lowering and body weight loss over 16 weeks in adults with type 2 diabetes - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/1167_879333/Slide1.jpg)
Oral small molecule GLP-1 receptor agonist danuglipron (PF-06882961) results in glucose lowering and body weight loss over 16 weeks in adults with type 2 diabetes - Media Centre | EASD
Pfizer - Today is World Diabetes Day! We are determined to further research on therapies for life-threatening diseases like diabetes. | Facebook
![Neue Erkenntnisse zu Diabetes insipidus: Promotionspreis für nephrologische Forschung von Dr. Markus Rinschen Neue Erkenntnisse zu Diabetes insipidus: Promotionspreis für nephrologische Forschung von Dr. Markus Rinschen](https://www.medizin.uni-muenster.de/fileadmin/_processed_/b/c/csm_b15f343dac97b9e664976e534cc46088_1d1a05761d.jpg)
Neue Erkenntnisse zu Diabetes insipidus: Promotionspreis für nephrologische Forschung von Dr. Markus Rinschen
![The American Diabetes Association Receives Health Equity Grant from the Pfizer Foundation to Help Improve the Health of Black Communities in the U.S. | ADA The American Diabetes Association Receives Health Equity Grant from the Pfizer Foundation to Help Improve the Health of Black Communities in the U.S. | ADA](https://diabetes.org/sites/default/files/styles/16_9_medium_700x394/public/2022-05/Pfizer%20Grant.png)
The American Diabetes Association Receives Health Equity Grant from the Pfizer Foundation to Help Improve the Health of Black Communities in the U.S. | ADA
![NIH research highlights increased post-COVID-19 risk of pediatric diabetes, Pfizer vaccine's effectiveness in preventing MIS-C in adolescents and teens | AHA News NIH research highlights increased post-COVID-19 risk of pediatric diabetes, Pfizer vaccine's effectiveness in preventing MIS-C in adolescents and teens | AHA News](https://www.aha.org/sites/default/files/styles/900x400/public/2018-04/NIH%20research.jpg?itok=6ZPUHpxg)